Takeda expands in gene therapy with $900m R&D deal
Takeda signs R&D agreement with Carmine for the development of two non-viral gene therapies.
Takeda signs R&D agreement with Carmine for the development of two non-viral gene therapies.
Pfizer and BioNTech release positive results from Phase I/II trials investigating their mRNA vaccine against COVID-19.